mbp's new competitor ???????, page-7

Gominer, I'm afraid you are wrong re phase III clinical trial for Metabolic's compound. It will most certainly require the full gamut of traditional testing particularly because many of our own hormones exert unwanted actions if given outside the normal endogenous levels and secretion protocols. eg steroid hormones and growth hormone itself (of which the Metabolic compound is a fraction) will cause untoward effects if given exogenously at abnormal levels.

Bottom line, no shortcuts...